The device could upend treatment for the 33 million to 45 million Americans with severe allergies to food and other triggers.

FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at ...

SoundHealth launched a new feature in its AI-powered health care app that will give users personalized allergy forecasts to ...

Whether it’s allergies, a sinus infection or runny nose … many people turn to nasal sprays for quick relief. And now, there’s growing interest in other nasal spray products … such as vaccines, and ...

The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen ...

ARS Pharmaceuticals' neffy, a needle-free nasal spray for allergies, receives FDA approval, driving stock price up 120%. Read ...

We came across a bullish thesis on ARS Pharmaceuticals (SPRY) on Value Degen’s Substack by Unemployed Value Degen. In this ...

Human factor studies showed that adults without knowledge of the disease or device (e.g. a babysitter or a teacher), were able to successfully use the device by simply reading the instructions. These ...

ARS Pharmaceuticals Inc. submitted a supplemental New Drug Application (sNDA) for a1 mg dose of nasal spray neffy, to treat ...

Food allergies, symptoms, and treatments explained by paediatricians in Chennai, including the importance of breast-feeding ...